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Abstract 
In order to operate a process which uses immobilized enzymes at constant conversion and constant 
capacity, the refreshment of the enzyme must be continuous. In this paper, two reactor types with 
continuous refreshment of the biocatalyst are discussed: the stirred tank and the multistage fluidized 
bed. A method is presented for dimensioning a reactor in such a way that the costs for the conversion 
of substrate to product are minimized. These costs are calculated as the sum of the biocatalyst consumption 
and overall reactor costs. 
In contrast with the stirred-tank reactor, the multistage fluidized bed can be operated at a non-uniform 
temperature. For the glucose isomerase process, an optimal temperature gradient results in a small 
reduction in the biocatalyst consumption (+ 5%). It is concluded that, in general, a temperature gradient 
will only favour the economy of processes with relatively expensive biocatalysta. 
Compared with conventional reactor types, such as the continuous stirred-tank reactor and the fixed- 
bed reactor, the multistage fluidized-bed reactor can improve the economy of an enzyme-catalysed reaction 
signitkantly. 
1. Introduction 
Enzymes show a relatively high activity at mod- 
erate temperatures and they are often stereospecific 
and/or regiospecik in their catalytic activity. A 
disadvantage is, however, their sensitivity to en- 
vironmental conditions. They are easily poisoned 
by, for example, metal ions and are only active over 
a limited range of temperatures and pH values. It 
is therefore essential that processes using enzymes 
as biocatalysts are operated at well-dellned and 
carefully chosen conditions. 
The glucose isomerase process described by 
Oestergaard and Knudsen [ 1 ] provides a good ex- 
ample of an enzyme dependent process. A glucose 
syrup, which is produced from corn starch, is partly 
converted into a 42 wt.% fructose syrup by im- 
mobilized glucose isomerase. The sweetening ability 
of this high fructose corn syrup (HFCS) is ap- 
proximately equal to that of sucrose [2]. Insoluble 
impurities in the influent glucose syrup, such as 
wax and proteins, are removed by filtration. Soluble 
impurities, such as peptides, amino acids and salts, 
are removed by treatment with active carbon fol- 
lowed by ion exchange. After these purification steps, 
the glucose syrup enters the reactor section for 
isomerization. A long syrup residence time will cause 
byproduct formation and a pH decrease. In order 
to minimize the formation of byproducts, and also 
because the pH influences both the activity and the 
stability of the enzyme, a short residence time in 
the reactor section is thus important. Therefore, as 
with most reactions involving immobilized enzymes, 
fixed-bed reactors are generally used. An additional 
problem is that, while the reactor temperature must 
be high enough to prevent microbial contamination, 
a lower temperature would favour the cumulative 
productivity that can be obtained with the enzyme. 
At a high temperature the biocatalyst is less stable, 
but, because it is more active, a smaller reactor 
volume is needed. Therefore there is an optimization 
problem. 
Regardless of the reactor temperature, the enzyme 
in the reactor will have lost most of its activity 
after a certain operating time and must be replaced. 
As it is desirable to maintain a constant conversion, 
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this means that continuous adjustment of the sub- 
strate flow rate is necessary. In order to reduce 
these flow adjustments, a configuration of reactors 
in series and parallel is often used and the biocatalyst 
is changed sequentially. Nevertheless, a configu- 
ration of six reactors still results in fluctuations of 
+ 10% of the average flow rate [ 1 ]. The substrate 
solution flows through the reactors in the direction 
of increasing enzyme activity. This allows any harm- 
ful contaminants still present in the glucose syrup 
to adsorb on the more deactivated biocatalyst, pro- 
tecting the fresh enzyme from poisoning reactions. 
In this paper, we describe the design and optim- 
ization of an alternative to this type of process. 
Central to this new development is a multistage 
fluidized-bed reactor (MFDR) with continuous re- 
freshment of the deactivating biocatalyst which has 
been described in detail by Vos et al. [ 31. The 
biocatalyst is transported from the top of the reactor 
downwards through holes in distributor plates by 
periodic inversion of the normally upward liquid 
flow. Frequent transport of small quantities results 
in a constant biocatalyst hold-up in each reactor 
compartment (Fig. 1). Compared with a series of 
fixed-bed reactors, the advantage of this system is 
that it can be operated at a constant flow rate and 
conversion. An additional advantage is the reduced 
danger of fouling and, in the case of gel immo- 
bilization, the circumvention of the risk of a high 
pressure drop over the reactor which can cause 
compression and deformation of the biocatalyst 
particles [ 41. Furthermore, the addition and removal 
of biocatalyst particles are continuous and auto- 
matic. A possible disadvantage of the MFBR is the 
requirement of biocatalyst particles with a more or 
less uniform diameter and density [ 5 1. For reactions 
that require continuous pH control to compensate 
for a possible pH change due to the reaction, such 
product out 
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Fig. 1. Counter-current MFBR for use with immobilized enzymes, 
with frictional refreshment of enzymes. 
as the production of 6-amino-penicillanic acid (6- 
APA) [6], a series of well-mixed reactors might be 
preferred to an MFBR with a plug flow characteristic. 
As already mentioned, the operating temperature 
of the reactor influences the activity and the stability 
of the immobilized biocatalyst, and thus also the 
size of the reactor. Therefore process optimization 
and reactor design have to be studied simultaneously. 
During previous work on the optimal temperature 
control policy for enzyme-catalysed reactions in a 
batch reactor, it was shown that small savings in 
biocatalyst consumption could be attained by in- 
creasing the temperature at the end of the reaction 
time [ 71. For immobilized glucose isomerase in a 
fixed-bed reactor, it was shown that, if the reactor 
temperature was increased with the aging of the 
biocatalyst, savings of up to more than 10% are 
possible [ 8 ]. For the MFBR this implies that a 
somewhat higher temperature in the bottom com- 
partments would be beneficial. This could, for ex- 
ample, be realized by a relatively high temperature 
of the influent. As the reactor loses heat to the 
surroundings, this would result in a temperature 
gradient as the liquid passes up the reactor. 
The aim of this work is to determine the optimal 
process conditions for reactors using continuous 
refreshment of a biocatalyst which gradually be- 
comes deactivated, in particular the MFRR. Optim- 
ization implies the search for those values of the 
process optimization variables that result in an 
extreme (i.e. maximum or minimum) of some pro- 
cess property which is defined by an objective 
function. Since the production of chemicals is an 
economic activity, the discounted cash flow rate of 
return (DCFRR) is the best property to be maximized. 
The DCFRR is the interest rate at which the net 
present value of the process is zero. Thus expenses 
or earnings at the beginning of the project weigh 
more heavily than later cash flows. Because un- 
certainties such as price fluctuations during the 
entire life time of the process are involved in this 
method, costs minimization for studies during the 
design phase is generally regarded as a good al- 
ternative to the DCFRR method [9]. 
In order to relate costs functions to processes 
which use enzymes which gradually become deac- 
tivated, we start with the presentation of a model 
for the MFBR which has been described more ex- 
tensively elsewhere [ 31 and verified with experiments 
using immobilized glucose isomerase [lo]. In order 
to illustrate the use of this generally applicable 
optimization strategy, its application for the con- 
tinuous stirred-tank reactor (CSTR) will be dis- 
cussed. Based on a simplified model, an analytical 
expression for the optimal CSTR temperature is 
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derived. For the MFBR, the problem is more complex 
and a numerical method for design and process 
optimization is presented. The minimization of the 
costs for the production of HFCS is also illustrated. 
2. Model for the multistage fluidized-bed 
reactor 
To describe the deactivation of the biocatalyst, 
a I%&-order model is used. This is often sufFiciently 
accurate to describe the enzyme deactivation kinetics 
[ 11 I. The biocatalyst is immobilized in spherical 
particles of uniform composition. Furthermore, the 
reactor is assumed to operate at a constant pH, 
while the temperature is taken as a variable in order 
to optimize the reaction conditions. The relationship 
between temperature and enzyme activity can be 
described by the Arrhenius equation 
k,‘(T)=ok,(T)=& exp 
In this equation, o is the fraction of the initial 
amount of enzyme that is still active. The first-order 
deactivation is based on a one-step mechanism with 
the assumption that the biocatalyst can only exist 
in two different states, active and inactive: 
G&i”, - G-e (2) 
The first-order deactivation rate constant of this 
one-step deactivation reaction is described as fol- 
lows: 
(3) 
The biocatalyst activity in each reactor com- 
partment can be determined from the assumptions 
that there is perfect particle mixing in each com- 
partment and that the mean biocatalyst activity in 
a compartment can be described by the activity 
corresponding to particles wlth an age equal to the 
mean residence time of the particles in that com- 
partment. In general, this is a simplification of the 
real situation where particles of different ages, and 
thus different activities, are present in a reactor 
compartment. However, for first-order deactivation, 
the segregation of biocatalytic activity does not 
influence the mean value of biocatalyst activity in 
the compartments. Thus, for a reactor with N com- 
partments numbered from n = 1 at the bottom to 
n = N at the top, first-order deactivation and a total 
biocatalyst residence time of 7b in the reactor, the 
fraction of active biocatalyst in a compartment n 
is given by 
(4) 
For this equation, a uniform temperature in every 
reactor compartment has been assumed. 
For the substrate, radial gradients are assumed 
to be absent. The transport of the liquid phase 
through each reactor compartment is described by 
plug flow with axial dispersion. A four-tanks-in- 
series model is suitable for quantifying the axial 
dispersion in a compartment of the MFE3R [ 10, 12 1. 
For m liquid mixing zones per reactor compartment, 
the following balance holds for such a mixing zone: 
CL&l -CLA!2arl R 
m Ov 
The reactor model is solved by calculation of the 
Da, number for every compartment using eqn. (4), 
followed by solving the mN balances for the liquid 
mixing zones starting at the bottom of the reactor. 
Expressions for the dimensionless bulk concentra- 
tion cL, the dimensionless concentration dependence 
vL of the reaction rate and the Da, number, which 
represents the ratio of the maximum reaction rate 
to that convective transport, are given in Table 1 
for various kinetic rate equations. The overall ef- 
fectiveness factor 77, accounts for the decrease in 
reaction rate inside the particle due to external 
mass transfer resistance and diffusion limitation. 
The overall effectiveness factor is dependent of o, 
and qov does not exhibit a first-order dependence 
on the enzyme age. Therefore the mean value of 
the effectiveness factor in a reactor compartment 
is influenced by the fact that not all particles have 
the same age and thus the same activity. This is 
not incorporated in eqn. (5), but the inaccuracy 
introduced by not taking the segregation of bio- 
catalytic activity into account in the calculation of 
the mean value of the effectiveness factor is reduced 
with an increase in the number of reactor com- 
partments. Various methods for calculating the ef- 
TABLE 1. Dimensionless numbers for various kinetic rate equs- 
tions 
Kinetics (Dal>, 
Michael&-Menten 
Zero order 
U-wKwx~” L SI. 
uoKsr l+c‘ K, 
Cl- l )Hko o” 
u&P 
1 
SL. 
so 
Reversible first-order (1 -wJG o, S 
u, 
CL - %eq $ 
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fectiveness factor for enzyme kinetics have been 
discussed and compared by Vos et al. [ 131. 
3. Process optimization strategy 
The process which is the subject of this optim- 
ization study involves a reaction which is catalysed 
by an immobilized enzyme. It might be part of a 
larger continuous production plant, and thus the 
process is characterized by a specified capacity and 
feed composition. The degree of conversion is dic- 
tated by the desired quality of the product stream. 
In order to optimize the reactor design, the total 
costs function can be minimized. A general costs 
function of a chemical process is as follows [9]: 
The total costs per unit of time consist of costs 
&, for raw materials, costs &,P for disposal of 
waste materials, and variable costs I$,~ and fixed 
costs cm. In this particular case, the flow rate and 
compositions of the reactor influent and effluent 
are iixed; thus, when minimizing the total costs of 
the process, only the variable and fixed costs need 
to be taken into account. The fixed costs, or overall 
reactor costs, can be subdivided into truly iixed 
costs (e.g. personnel) and investment-related fixed 
costs (e.g. insurance, maintenance and depreciation 
costs). For this process, the variable costs are mainly 
determined by biocatalyst consumption and energy 
requirements. However, biocatalysts are only active 
and stable in a narrow temperature range; thus the 
energy requirements can be regarded as not affected 
by the optimal choice for the reactor temperature. 
By doing so, the optimization problem can be sep- 
arated into technological and economic problems. 
The technological aspect is the determination of 
the operating temperature at a given biocatalyst 
residence time, substrate flow and conversion, such 
that the hold-up of biocatalyst (i.e. the total amount 
of biocatalyst present in the reactor) is minimized. 
This simultaneously minimizes the biocatalyst con- 
sumption (variable costs) and the reactor dimensions 
(fixed costs), and thus also the total costs function. 
The economic aspect is to make an optimum se- 
lection from the combinations of biocatalyst resi- 
dence time and operating temperature that can be 
regarded as technological suboptima. This is easily 
illustrated for a continuous stirred-tank reactor 
(CSTR) with continuous replacement of the enzyme. 
4. Illustration of the optimization strategy 
for a continuous stirred-tank reactor 
The three most important process variables which 
determine the size of a CSTR, and thus the in- 
vestment-related fixed costs, are the residence time, 
the hold-up of biocatalyst and the operating tem- 
perature. Analogous to the model of the MFBR, it 
is assumed that the performance of the well-mixed 
biocatalyst particles can be described by the activity 
and effectiveness factor equal to those of particles 
with an age equal to the mean residence time of 
the biocatalyst. For a single stirred reactor, this 
might be a somewhat rough approach, but it can 
be used quite well to illustrate the optimization 
strategy. As a result, the overall reaction rate con- 
stant, in the case of first-order deactivation, is given 
by the following equation: 
k,’ = k,w= 
kr(ll? 
1 + TL, k,(T) 
(7) 
For given values of 7b and T, the hold-up of bio- 
catalyst follows from k,’ and the desired conversion; 
thus only two of the three process design variables 
can be chosen freely. From eqn. (7), the effect of 
temperature on the overall reaction rate constant 
for various biocatalyst residence times is shown in 
Fig. 2. Arbitrary parameter values have been used 
together with first-order reaction kinetics. The max- 
imum attainable activity is higher for short bio- 
catalyst residence times. A high temperature causes 
rapid deactivation and thus a low mean activity; at 
low temperatures the deactivation reaction is very 
slow and the activity is almost independent of the 
biocatalyst residence time. 
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Now we shall focus on the technological aspect 
of the optimization problem: the determination of 
combinations of 71, and T for which the hold-up of 
biocatalyst is minimal. Thus the reaction rate per 
unit of biocatalyst is maximal. Maximization of the 
overall reaction rate constant results in a maximal 
reaction rate per unit of biocatalyst. Possible mass 
transfer resistances related to heterogeneous ca- 
talysis do not influence the optimum temperature 
of the CSTR. The optimal combinations of 7b and 
Tare therefore found by simply making the derivative 
of the reaction rate constant with respect to tem- 
perature equal to zero: 
ii! l- Tb kdO exp( -E&T) =o (8) 
(9) 
From this, it follows that an optimal operating 
temperature for a given biocatalyst residence time 
exists for E,>E,. In principle, the same approach 
as illustrated for the CSTR can be used for the 
MFBR. 
6. Application of the optimization strategy 
to the multistage tied-bed reactor 
Compared with the CSTR, the MFBR is a more 
complex reactor with more design parameters. How- 
ever, this does not necessarily increase the com- 
plexity -of the optimization problem. These extra 
parameters are determined by some conditions that 
are essential for successful operation of the MFBR, 
as will be discussed briefly. 
(1) Within a batch of immobilized biocatalyst 
particles, there always will be a certain spread in 
size. When particle mixing is incomplete, the smaller 
particles tend to accumulate in the top of a com- 
partment and, since the biocatalyst is mainly trans- 
ported from the bottom of a compartment, this 
causes an unequal residence time for small and 
large particles. Therefore for an efficient use of the 
biocatalyst it is essential that the particles are per- 
fectly mixed. The conditions under which particles 
can be mixed are dependent on the properties of 
the particles and liquid, and the scale of the reactor 
[5]. These conditions must be determined from full- 
scale experiments and can be related to the bed 
porosity, e.g. 0.6 Q EG 0.7. As a result, the required 
liquid velocity follows from the particle properties 
(diameter and density) and the demand for the bed 
porosity. The Richardson-Zaki [ 14 1 equation is often 
used for this purpose. 
(2) The diameter of the reactor is determined by 
the allowable liquidvelocity and the desired capacity. 
(3) For a single CSTR, particles with high and 
low activities are simultaneously removed from the 
reactor. For an MFBR, approximately plug flow 
transport of the biocatalyst can be realized by in- 
creasing the number of reactor compartments, and 
only particles with a low activity are removed from 
the reactor. The reactor efficiency improves with 
increasing number of compartments but requires a 
larger investment for extra distributor plates. It is 
not expected that this is a major cost factor in the 
overall process economics, and we therefore assume, 
somewhat arbitrarily, that ten compartments are 
used in order to achieve a limited degree of back 
mixing of the biocatalyst. If desired, the number 
of plates can be optimized by comparing the op- 
timization results for different numbers of com- 
partments. 
The resulting procedure for the optimal design 
of an MFBR is summarized in Fig. 3. For given 
values of the compartment temperatures, the bio- 
catalyst residence time and the number of reactor 
compartments, the active biocatalyst fraction ol, 
oN in each reactor compartment can be calculated 
from eqn. (4). From the temperature and the bio- 
catalyst activity in the compartments, the liquid 
residence time is found iteratively, such that the 
desired degree of conversion is attained. The bed 
height, which is proportional to the biocatalyst 
loading, is calculated from the liquid residence time 
and the liquid velocity. Because of a biocatalyst 
activity gradient and a possible temperature gradient, 
the effectiveness factor is different for every reactor 
compartment. Therefore the mass transfer resis- 
fig. 3. Diagram for the optimal design of an MFBR. 
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tances related to heterogeneous catalysis do influ- 
ence the optimal operating conditions of the MFBR, 
unlike those of the CSTR. 
The technological aspect of the optimization prob- 
lem is the determination of the temperatures in the 
reactor compartments at a given value of the bio- 
catalyst residence time, such that the hold-up of 
biocatalyst is minimized. A non-linear parameter 
estimation routine must be used to find these tem- 
peratures. From the technologically optimal com- 
binations of temperature and biocatalyst residence 
time which can be obtained by following this pro- 
cedure, the economically optimal combination can 
be selected by minimization of a total costs function. 
6. A case study: optimal design of a 
multistage fixed-bed reactor for the 
production of bigb fructose corn syrup 
As an example, a case study for the optimization 
of the glucose isomerase process in an MFBR is 
presented. A typical capacity for an HFCS production 
unit is 100 ton day- ’ dry weight [ 11. The feed and 
product stream compositions have been taken from 
published data [ 21 and are listed in Table 2. Like 
most enzymatic reactions, heat effects can be ne- 
glected. The reaction rate can be described by 
reversible first-order kinetics according to 
v(S) =k,(S-St?,) 
where 
(IO) 
s = S-bP 
-2 1 +Keq 
(111 
In general, numerical techniques must be used for 
calculation of the effectiveness factor for reversible 
reaction kinetics. Only for irreversible zero- and 
first-order reactions have analytical solutions been 
derived. However, when S,, is a constant within the 
biocatalyst particle, the differential equation and 
boundary conditions that describe the concentration 
profile in the catalyst pellet are mathematically 
equivalent to the differential equation for irreversible 
TABLE 2. Feed and product stream compositions for the high 
fructose corn syrup process 
Inlet 
(% of dry weight) 
Outlet 
(W of dry weight) 
Dry weight 45 45 
Glucose 95 53 
Fructose 0 42 
Oligosaccharides 5 5 
first-order kinetics. The effectiveness factor follows 
from the solution of this differential equation; thus 
by assuming that S, is constant the first-order 
effectiveness factor expression can be applied. Be- 
cause the mass transport properties of S and P are 
similar, their spatial concentration curves are almost 
symmetrical and this results in a nearly constant 
value of S+ P and therefore, from eqn. (1 l), in a 
constant value of S,. Therefore, eqn. (12), which 
is the expression for the overall effectiveness factor 
for first-order kinetics [ 131, can be applied for this 
equilibrium reaction: 
( 
3P 3@ -I 
“rl ov= 
34, coth(3@)- 1 + Bi 1 
(12) 
For the model biocatalyst, Maxazyme GI Immob of 
Gist-brocades n.v. was selected. The kinetic and 
physical properties of the spherical brown particles 
have been taken from Roels and van Tilburg [ 151 
and are listed in Table 3. It should be noted that 
the effective diffusivity is not given as a function 
of temperature. The relationship between the tem- 
perature and the reaction rate constant has been 
determined assuming a constant effective diffusivity; 
thus the influence of the temperature on the effective 
diffusivity is incorporated in the reaction rate con- 
stant. This will not introduce large inaccuracies 
because, in the narrow temperature range of interest, 
the variation in the diffusivity with the temperature 
is small compared with the variation in the reaction 
rate constant. 
The viscosity of a syrup with 45% dry weight 
was correlated as a function of the temperature by 
interpolation of published data [ 161, the density is 
taken from the Handbook of Chemistry and Physics 
[171. 
The particle density and fluidization behaviour 
were analysed in a tubular reactor with an internal 
diameter of 0.02 m which was thermostated at 333 
K. The initial particle density was approximately 
1100 kg rne3, but this increased when the particles 
were soaked with syrup and fluidization was possible. 
The liquid fraction was determined at various liquid 
velocities and fitted with the Richardson-Zaki 
TABLE 3. Physical and kinetic data relevant to the high fructose 
corn syrup process 
4.83 X 10’ exp( - 9500/T) s-’ 
1.75X10z5 exp(-24400/T) s-’ 
6.7 X IO-” mz s-’ 
6~10~~ m 
28.8 exp( - 1100/Z’) 
14.44x10e3 exp[-0.04(T-273)]+0.90x10-3 Pas 
1195 kg mW3 
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equation 
uo - =errra 
u, 
(13) 
The results are shown in Fig. 4. The exponent, nRz 
was determined to be 2.9 and, from the terminal 
velocity, the particle density was calculated at 12 10 
kg mV3. 
The external mass transfer coefficient was cal- 
culated from a correlation by Tournie et al. [ 181. 
The values obtained for the Bi number resulted in 
an external effectiveness factor of approximately 
0.96; thus the external mass transfer resistance only 
has a small effect on the reaction rate. 
Now that we have determined all the process 
parameters, it is possible to simulate reactor per- 
formance. A normal operational lifetime for im- 
mobilized glucose isomerase is 50 days [ 19 1. For 
this biocatalyst residence time, we compared several 
approaches for the determination of the optimal 
operating temperature. The reactor temperature can 
be treated as constant or it can be described by a 
polynomial (NP > 2): 
T,=p, +,$2pi(N-n)i-1 (14) 
Alternatively, we could have used an optimization 
method involving all the compartment temperatures. 
The advantage of the approach used here is that 
a ten-compartment reactor can be optimized rather 
accurately using only a few parameters. From the 
various hill-climbing routines that have been de- 
veloped for numerical parameter optimization in a 
multidimensional space, the direct grid search [20] 
was applied. 
Up to NP = 4, the parameter values p,, p,, p3 and 
p4 were calculated such that the hold-up of bio- 
catalyst in the reactor was miniied. The optimal 
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Fig. 4. Superficial liquid velocity and bed porosity for immobilized 
glucose isomerase in 45 wt.% glucose solution. 
temperature was also calculated from eqn. (9). The 
results are listed in Table 4. Figure 5 gives a graphical 
representation of various parameters in the iso- 
merization process for N,=4. 
Comparing the biocatalyst consumption values 
obtained with the various optimization methods 
used, it appears that eqn. (9) gives a reasonable 
approximation of the optimum when using a uniform 
reactor temperature. The savings in biocatalyst con- 
sumption that can be obtained by imposing a tem- 
perature gradient on the reactor are relatively small 
and of the order of magnitude of 5%. 
Estimating the cost of the biocatalyst as US$9 
kg-’ and the market price of HFCS as US$O.5 kg-’ 
dry weight [2 11, a reduction of the biocatalyst 
consumption of 5% results in a capital saving of, 
at most, US$22 000 year-’ which is equivalent to 
approximately 0.12% of the price of the syrup 
produced. This must be compared with the cost of 
controlling the temperature of the reactor, such that 
the calculated temperature profile (Fig. 5) is main- 
tained. The residence time of the syrup in the reactor 
is approximately 2 h; thus the superficial liquid 
velocity is less than 2X 10m3 m s-‘. This results 
in a low heat transfer coefficient and, even for a 
wall temperature of 273 K, the cooling capacity is 
too low to achieve the desired temperature gradient 
of approximately 10 K. Thus, in order to operate 
this process with minimal biocatalyst requirements, 
additional investments have to be made for internal 
cooling devices, or the process should be carried 
out in a several parallel reactors with wall cooling. 
Taking this into consideration, it is expected that 
for isomerization in an MFBR, a reactor without 
thermal insulation is the best choice, taking ad- 
vantage of the small temperature gradient caused 
by cooling against the surroundings. 
For the HFCS process in an MFBR at constant 
temperature, the technological suboptima were de- 
termined for various biocatalyst residence times 
(Fig. 6). When the biocatalyst residence time is 
increased, the optimum reactor temperature de- 
creases. To compensate for this, the biocatalyst 
hold-up per compartment is increased. The residual 
activity o1 in the bottom compartment is more or 
less constant, at approximately 40%. Intuitively, one 
would possibly think that, in order to obtain max- 
imum productivity per unit of biocatalyst, it is 
advantageous to use the biocatalyst down to a low 
residual activity. However, the optimum is deter- 
mined by two factors that act in opposite directions. 
Although the optimum lies at 40% residual activity, 
the biocatalyst can be used to, for example, 25% 
residual activity. This requires a higher reactor 
temperature, resulting in a higher reaction rate 
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TABLE 4. Influence of optimization method on estimated reactor dimensions for 100 tons day-’ dry weight high fructose corn 
syrup production in a multistage fluidised-bed reactor (mass flow, 2.572 kg s-r; biocatalyst residence time, 4.32 X lo6 s (= 50 
days); m=4; bed porosity, 0.65; N= 10; S,,=513 kg me3; [=0.4421) 
Optimization method Value 
Equation (9) ND=1 NP=2 ND=3 N,-4 
Biocatalyst per reactor compartment (kg) 679.1 669.3 644.8 639.8 639.3 
Compartment height (m) 1.39 1.37 1.32 1.31 1.31 
Reactor diameter (m) 1.21 1.21 1.21 1.21 1.21 
Top temperature (IQ 330.8 332.3 328.7 330.3 330.3 
Bottom temperature (K) 330.8 332.3 337.4 339.9 340.5 
Residual activity w1 0.511 0.398 0.283 0.247 0.239 
Biocatalyst consumption relative to NP = 1 (%) 101.5 100.0 96.3 95.6 95.5 
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Fig. 5. Glucose concentration, biocatalyst activity, overall effectiveness factor and reactor 
@ammeters as in Table 4; N,=4). 
Fig. 6. Residual biocatalyst activity wl, reactor temperature and 
biocatalyst hold-up for 100 tons day-’ dry weight HFCS reactor: 
optimization for ND = 1 as a function of the biocatalyst residence 
time. 
constant (eqn. (l)), but the total hold-up of active 
biocatalyst is lower. 
The glucose isomerase biocatalyst considered here 
must be used to approximately 40% residual activity, 
regardless of the biocatalyst residence time. When 
taking into account the temperature restrictions, in 
order to keep the process free from microbial con- 
tamination, the picture changes drastically (Fig. 7). 
This figure is almost equivalent to Fig. 6, except 
that the range of allowable temperatures is restricted 
temperature for the HFCS process 
Fig. 7. The same as Fig. 6, but with a minimum operating 
temperature of 328 K. 
by a minimum at 328 K. For biocatalyst residence 
times longer than approximately lo7 s, the reactor 
temperature is higher than without this restriction. 
This causes a low residual biocatalyst activity; thus 
more biocatalyst per compartment is needed to keep 
the degree of conversion at its specified value. 
Having illustrated how to obtain combinations of 
operating temperature and biocatalyst residence 
time, the task of determining the economic optimum 
from these technological suboptima remains. Dif- 
ferent choices of biocatalyst residence time resulted 
in different values of the reactor temperature (in 
H.J. Vos et al. / Reactors with con.4inuou.s transport of immobilized enzgm.e B9 
this rase Ute cfpiirrtitiun vzriabk), -and The hold- 
up of biocatalyst. The hold-up of biocatalyst is 
proportional to the reactor volume; thus it is a 
measure for the investment-related fixed costs. This 
can be quantified by the six-tenths rule which is 
formulated by eqn. (15). The parameter al stands 
for the annual investment-related fixed costs. These 
Zr-e est-imtted as 30B of &iY? irrves&iWrrt custs fur 
a reference reactor. The reactor which was &men- 
sioned forNP = 1 in T&&e 4 is &osen as tisrekrence 
(biocatalyst hold-up, 6693 kg; N= 10; H = 13.7 m; 
diameter, 1.21 m). The investment costs for this 
reactor are estimated as US$500 000; thus a, is 
approximately US$150 000 year-‘. The consump- 
tion of biocatalyst is the most important variable 
cost factor that is changed by different values of 
the biocatalyst residence time. The biocatalyst cost 
is given by eqn. (16) where a2 is the biocatalyst 
price (USt9 kg- ‘). Cther cost factors which are 
incorporated in eqn. (6) are independent of the 
biocatalyst residence time and do not need to be 
taken into account when minimizing the total costs 
function: 
investment-related fmed costs 
biocatalyst hold-up ‘.’ = (+ 
1 reference hold-up (15) 
biocatalyst cost 
= a2 X biocatalyst consumption rate (16) 
In Fig. 8, the economically optimal reactor design 
is determined graphically for these values of the 
parameters a, and u2. The process capacity is 100 
ton HFCS day- ’ and the reactor is assumed to 
operate at a uniform temperature which should 
exceed 328 K. The choice of the biocatalyst residence 
time corresponds to the minimum of the sum of 
eqns. (15) and (16), and thus of the total cost 
lE6 lE7 3EB 
BiDCe.ta1ySt Feside”ce tmll IS, 
F’ig. 8. Dete rmination of the optimal biocatalyst residence time 
for the HFCS process with a capacity of 100 tons day-’ dry 
weight and a minimum operating temperature of 328 K (N= 10; 
NP= 1; o, =US$150 OOOyear-‘; a,=US$9 kg-‘; reference hold- 
up, 6693 kg biocatalyst). 
function. ?i?-ie econorriically optmid situation -B char- 
acterized by the minimum allowable temperature of 
328 K and a biocatalyst residence time of approx- 
imately 2.0 X 10’ s (+230 days). It is noted that 
this biocatalyst residence time is much longer than 
the previously mentioned 50 days. Nevertheless, 
this can hardly be explained by a too conservative 
es~ima~iurl of CI) as i&W&?a in T&?&s 5. 
The rcsu& oB.&ned by f3iis eco3mtic eya3uatio33 
of the te&uro10gic& su’boptima for N= 2 0 can be 
optimized further by taking the number of com- 
partments as an additional optimization variable. 
Therefore economic optima for a range of reactors 
need to be compared, taking a1 as a function of 
the total number of compartments. When the in- 
fluence of the number of compartments in the MFRR 
on a, is estimated as a, =US$(120 000 + 3OOON) 
year- ‘, the economically optimal situation as a 
function of N is given in Table 6 and Fig. 9. For 
all the process simulations, the optimal temperature 
equaIs the minimal alIowabIe temperature. It follows 
that, from an economic point of view, a reactor 
with six compartments results in minimization of 
the total costs for conversion of a glucose syrup 
to a 42 wt.% fructose syrup. These costs are only 
a little more than 2% of the market price of the 
syrup produced. 
7. Discussion and conclusions 
The activity and stability of biocatalysts are in- 
fluenced by environmental parameters. Therefore 
the reaction conditions contribute significantly to 
the overall process economy. For reaction systems 
with continuous refreshment of such a biocatalyst, 
the process optimization can be split into technical 
and economic parts. The technical aspect is the 
determination of the optimal temperature at a given 
biocatalyst residence time. At this temperature, the 
biocatalyst productivity is maximal, resulting in a 
minimization of both the biocatalyst consumption 
and the hold-up; thus the smallest possible reactor 
is obtained. Costs functions for biocatalyst and 
investment-related 6xed costs can be used to de- 
termine the economic optimum from various pos- 
sible suboptimal combinations of biocatalyst resi- 
dence time and operating temperature. 
From a study of the glucose isomerase process 
in an MFHR, it appears that only a small reduction 
in biocatalyst consumption ( f 5%) can be obtained 
by imposing a temperature gradient on the reactor. 
It is not likely that this will be very different for 
other biocatalysts and it is concluded that, in general, 
only the use of expensive biocatalysts may justify 
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TABLE 5. Influence of a, on optimal process conditions and costs for 100 tons day- 1 dry weight production of high fructose 
corn syrup in a multistage fixed-bed reactor (2’,,,,=328 K; N=lO; N,= 1; m=4; e=0.65; &=513 kg me3; 5=0.4421; mass flow, 
2.571 kg s-r; aa=US$9 kg-‘; reference hold-up, 6693 kg) 
$S$ year-‘) 
100000 
150000 
200000 
300000 
500000 
Biocatalyst Biocatalyst Investment Biocatalyst 
hold-up in MFBR residence time related fixed costs cost 
(kg) (s) (US$ year-‘) (US8 year-‘) 
13.5x103 2.40 x lo7 152x lo3 159 x lo3 
12.0x 103 2.00x lo7 213x lo3 171 x 103 
11.5x103 1.82~10~ 276x lo3 179x 103 
10.5x103 1.51 x 107 393x 103 196x lo3 
9.5 x lo3 1.20x lo7 618X 103 225 x lo3 
Total costs 
(US$ year-‘) 
311x103 
384X 103 
455 x 103 
589X 10s 
843x lo3 
TABLE 6. Influence of N on various process conditions and 
costs for 100 ton day-’ dry weight production of high fructose 
corn syrup in a multistage fixed-bed reactor (Tmin = 328 K, NP = 1 
m=4, c=O.65; S,,=513 kg mW3; 5=0.4421; mass flow, 2.571 
kg s-‘; a,=US$9 kg-‘; a, =US$(lZO 000 + 3000 N) year-‘; 
reference hold-up = 6693 kg) 
N Biocatalyst 
hold-up ;“L) 
(kg) 
1 21.4~10~ 0.3050 328 2.64 x lo7 
2 16.1 x lo3 0.2461 328 2.34 x lo7 
3 14.5x 103 0.2228 328 2.26x lo7 
4 13.7x 10s 0.2109 328 2.21 x lo7 
5 13.3x lo3 0.2046 328 2.17x lo7 
6 12.9x103 0.2009 328 2.13x lo7 
7 12.7x103 0.1989 328 2.11x107 
8 12.5x lo3 0.1979 328 2.08x 10’ 
9 12.3 x lo3 0.1978 328 2.06 x lo7 
10 12.2 x 103 0.1968 328 2.05 x lo7 
11 12.1 x 103 0.1980 328 2.02 x lo7 
12 12.0x 103 0.1999 328 2.00 x lo7 
100000 i. 
1 2 3 4 5 6 7 8 9 101112 
Nuder of compartments in MFBR 
Fig. 9. Minimal costs for operation of an MFBR for the production 
of HFCS with a capacity of 100 tons day-’ dry weight as a 
function of the number of compartments; A, investment related 
fixed costs; +, biocatalyst costs; 0, total costs. 
the higher investment costs of precise control of 
a temperature profile over the MFHR. It follows 
from Fig. 9 that, when taking the costs for N= 1 
as an estimation of the costs for a CSTR, an enzymatic 
conversion in an MFHR can be carried out ap- 
proximately 20% cheaper than in a CSTR. The 
advantage of the MFRR over the llxed-bed reactor 
is that, in order to operate the process at a constant 
capacity and conversion, only one MFBR is needed 
while at least six fixed-bed reactors are required 
[ 31. According to the sixth-tenths rule, this results 
in lower investment costs for the MFRR. Further- 
more, a fixed-bed reactor requires a cycle of shut- 
down, reloading with fresh enzyme and start-up 
while the handling of solids for the MFBR is con- 
tinuous and automatic. The amounts of enzyme 
required for the MFRR and a fixed-bed reactor are 
approximately equal, as shown previously [3]. It is 
concluded that, compared with the conventional 
reactor types (CSTR and fixed bed), the use of an 
MFHR may significantly favour the economics of 
an enzyme-catalysed reaction step. 
However, when making a choice for a reactor 
type, some practical considerations need to be taken 
into account. It is, for example, questionable whether 
the MFI3R is an attractive reactor type for the HFCS 
process. Owing to the good operational stability of 
the biocatalyst, the residence time of the solids is 
very long for a continuous process. Furthermore, 
the residence time of the biocatalyst is long com- 
pared with fluctuations in the demand of HFCS, 
which is relatively small in the winter. It is concluded 
that the MFHR is not a generally applicable reactor 
type, but it might be a good alternative for some 
processes, such as the enzymatic purification of 
specific industrial waste-water streams [ 221. The 
optimization method presented can be applied gen- 
erally to design reactors that allow for continuous 
refreshment of an unstable biocatalyst. 
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Appendix A: Nomenclature 
Bi 
CL 
e 
Rpki+sI&,s, biot number 
dimensionless concentration, defined in Ta- 
ble 1 
costs per unit of time 
k d0 
k 
kr’ 
ko 
kl 
km 
K-3 
KM 
m 
nm 
N 
NP 
P 
R 
RP 
S -2 
SL 
SO 
so 
T 
u, 
u, 
vIna.x 
Greek 
E 
7) 0” 
CL 
VL 
5 
P 
a1 
a2 
*b 
Q, 
%a 
effective diffusivity (m2 s-i) 
Damkohler I number, defined in Table 1 
deactivation energy for biocatalyst (J mol- ‘) 
activation energy for reaction (J mol-‘) 
expanded bed height in reactor compartment 
(m) 
first-order enzyme deactivation constant 
(s-9 
initial first-order deactivation constant (s-r) 
general reaction rate constant for fresh bio- 
catalyst 
general reaction rate constant (dimensions 
unspecified) 
zero order rate constant inside particle (mol 
me3 s-r) 
first-order rate constant inside particle (s-r) 
initial value of general reaction rate constant 
Pm/Seq equilibrium constant 
Michaelis-Menten constant (mol rne3) 
number of liquid mixing zones per reactor 
compartment 
exponent in the Richardson-Zaki equation 
total number of reactor compartments 
number of parameters for temperature po- 
lynomial (eqn. (14)) 
product concentration (mol mP3) 
universal gas constant (J mol- ’ K- ‘) 
particle radius (m) 
equilibrium concentration (mol rne3) 
substrate bulk concentration (mol mw3) 
arbitrary substrate concentration (mol me3) 
substrate inlet concentration (mol me3) 
absolute temperature (K) 
particle free falling velocity (m s- ‘) 
superficial liquid velocity (m s-) 
maximum reaction rate inside particle (mol 
mm3 s-l) 
letters 
liquid fraction in fluidized bed 
overall effectiveness factor 
viscosity (Pas) 
dimensionless concentration dependence of 
the reaction rate for bulk concentrations 
conversion 
density (kg m-“) 
annual investment related fixed costs (US$ 
year- ‘) 
biocatalyst price (US$ kg-‘) 
biocatalyst residence tune in reactor (s) 
W, kr “2/o,,, s ‘12 first-order reaction modulus , 
active fraction of biocatalyst in compartment 
n 
